Fluoride Treatment and Risk of Fracture In Osteoporosis Patients
Loading...
Date
2018-03-14
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
faculty of Basic Medical Science - Libyan International Medical University
Abstract
Description
Osteoporosis is common systemic skeletal disease characterized
by low bone mass and microarchitectural deterioration of bone
tissue, leading to enhanced bone fragility and a consequent
increase in fracture risk”
• More common in postmenopausal
Sodium fluoride stimulates bone formation and increases
cancellous-bone mass
Sodium fluoride (NaF) was currently the only pharmacological
agent capable of stimulating bone formation through a direct
effect on the osteoblast
Keywords
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwised noted, this item's license is described as Attribution 3.0 United States
